Ever Source Wealth Advisors, LLC Biotechnology

Ever Source Wealth Advisors, LLC

$1.65 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
OVID Ovid Therapeutics Inc.	$37.3M	$0 0.0% of portfolio	21	Q4 2024 New
CELC Celcuity Inc.	$142M	$0 0.0% of portfolio	9	Q4 2024 New
RYTM Rhythm Pharmaceuticals, Inc.	$2.95B	$0 0.0% of portfolio	12	Q4 2024 New
SCPH Sc Pharmaceuticals Inc.	$91.2M	$0 0.0% of portfolio	46	Q4 2024 New
RCUS Arcus Biosciences, Inc.	$713M	$0 0.0% of portfolio	21	Q4 2024 Added 162.5%
COGT Cogent Biosciences, Inc.	$460M	$0 0.0% of portfolio	17	Q4 2024 New
ALLK Allakos Inc.	$23.7M	$0 0.0% of portfolio	477	Q1 2024 New
LQDA Liquidia Corp	$989M	$0 0.0% of portfolio	4	Q4 2024 New
VERU Veru Inc.	$41.7M	$0 0.0% of portfolio	46	Q4 2024 New
BMEA Biomea Fusion, Inc.	$82M	$0 0.0% of portfolio	12	Q4 2024 New
STRO Sutro Biopharma, Inc.	$80.9M	$0 0.0% of portfolio	61	Q4 2024 New
GRTS Gritstone Bio, Inc.	$2.19M	$0 0.0% of portfolio	1,724	Q3 2024 Added 165.64%
CDXS Codexis, Inc.	$257M	$0 0.0% of portfolio	35	Q4 2024 New
XFOR X4 Pharmaceuticals, Inc	$26.8M	$0 0.0% of portfolio	41	Q4 2024 New
PDSB Pds Biotechnology Corp	$38.7M	$0 0.0% of portfolio	431	Q4 2024 Added 155.03%
IDYA Ideaya Biosciences, Inc.	$973M	$0 0.0% of portfolio	3	Q4 2024 Reduced 78.57%
STOK Stoke Therapeutics, Inc.	$315M	$0 0.0% of portfolio	3	Q4 2024 New
AKRO Akero Therapeutics, Inc.	$2.22B	$0 0.0% of portfolio	9	Q4 2024 New
ADPT Adaptive Biotechnologies Corp	$1.17B	$0 0.0% of portfolio	86	Q4 2024 New
CDXC Chroma Dex Corp.	$372M	$0 0.0% of portfolio	10	Q4 2024 New
PHAT Phathom Pharmaceuticals, Inc.	$226M	$0 0.0% of portfolio	21	Q4 2024 New
ANVS Annovis Bio, Inc.	$14.6M	$0 0.0% of portfolio	83	Q2 2024 New
IMVT Immunovant, Inc.	$3.55B	$0 0.0% of portfolio	17	Q4 2024 Added 21.43%
RAPT Rapt Therapeutics, Inc.	$32.3M	$0 0.0% of portfolio	548	Q4 2024 Added 331.5%
LYRA Lyra Therapeutics, Inc.	$6.68M	$0 0.0% of portfolio	119	Q4 2024 New
ADCT Adc Therapeutics Sa	$123M	$0 0.0% of portfolio	77	Q4 2024 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	5	Q4 2024 New
GALT Galectin Therapeutics Inc	$90.9M	$0 0.0% of portfolio	46	Q4 2024 New
GBIO Generation Bio Co.	$31.9M	$0 0.0% of portfolio	75	Q4 2024 New
NKTX Nkarta, Inc.	$85.1M	$0 0.0% of portfolio	312	Q3 2023 New
ANNX Annexon, Inc.	$119M	$0 0.0% of portfolio	10	Q4 2024 New
ITOS I Teos Therapeutics, Inc.	$249M	$0 0.0% of portfolio	85	Q4 2024 Reduced 50.0%
NRIX Nurix Therapeutics, Inc.	$707M	$0 0.0% of portfolio	33	Q4 2024 New
INZY Inozyme Pharma, Inc.	$48.2M	$0 0.0% of portfolio	5	Q4 2024 New
DYN Dyne Therapeutics, Inc.	$682M	$0 0.0% of portfolio	3	Q4 2024 New
CCCC C4 Therapeutics, Inc.	$127M	$0 0.0% of portfolio	4	Q4 2024 New
TARS Tarsus Pharmaceuticals, Inc.	$1.16B	$0 0.0% of portfolio	7	Q4 2024 New
BCAB Bio Atla, Inc.	$11.3M	$0 0.0% of portfolio	646	Q4 2024 Added 96.35%
VRDN Viridian Therapeutics, Inc.\De	$610M	$0 0.0% of portfolio	6	Q4 2024 New
NVAX Novavax Inc	$552M	$0 0.0% of portfolio	73	Q4 2024 Added 143.33%
SANA Sana Biotechnology, Inc.	$493M	$0 0.0% of portfolio	142	Q4 2024 Reduced 55.9%
TERN Terns Pharmaceuticals, Inc.	$141M	$0 0.0% of portfolio	5	Q4 2024 New
EWTX Edgewise Therapeutics, Inc.	$1.67B	$0 0.0% of portfolio	18	Q4 2024 New
RXRX Recursion Pharmaceuticals, Inc.	$1.38B	$0 0.0% of portfolio	115	Q4 2024 New
HOWL Werewolf Therapeutics, Inc.	$37.5M	$0 0.0% of portfolio	33	Q4 2024 New
DAWN Day One Biopharmaceuticals, Inc.	$693M	$0 0.0% of portfolio	13	Q4 2024 New
NAUT Nautilus Biotechnology, Inc.	$146M	$0 0.0% of portfolio	100	Q4 2024 New
QSI Quantum Si Inc	$161M	$0 0.0% of portfolio	26	Q4 2024 New
JANX Janux Therapeutics, Inc.	$1.33B	$0 0.0% of portfolio	8	Q4 2024 New
VERV Verve Therapeutics, Inc.	$372M	$0 0.0% of portfolio	92	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.